Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.350
-0.020 (-1.46%)
At close: Dec 31, 2025, 4:00 PM EST
1.360
+0.010 (0.74%)
After-hours: Dec 31, 2025, 7:57 PM EST
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $119.17 million as of December 31, 2025. Its market cap has increased by 500.05% in one year.
Market Cap
119.17M
Enterprise Value
80.22M
1-Year Change
500.05%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $119.17M, a decrease of -53.53%. That is a compound annual growth rate of -16.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 119.17M | 308.99% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |